Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PF) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for Metlife (MET-PF) over the last 6 years, with Q3 2025 value amounting to $5.1 billion.

  • Metlife's Current Deferred Revenue rose 768.09% to $5.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 billion, marking a year-over-year increase of 768.09%. This contributed to the annual value of $4.6 billion for FY2024, which is 216.0% up from last year.
  • As of Q3 2025, Metlife's Current Deferred Revenue stood at $5.1 billion, which was up 768.09% from $4.9 billion recorded in Q2 2025.
  • In the past 5 years, Metlife's Current Deferred Revenue ranged from a high of $5.1 billion in Q3 2025 and a low of $3.6 billion during Q4 2021
  • Moreover, its 5-year median value for Current Deferred Revenue was $4.6 billion (2024), whereas its average is $4.5 billion.
  • Per our database at Business Quant, Metlife's Current Deferred Revenue skyrocketed by 1460.64% in 2021 and then surged by 216.0% in 2024.
  • Metlife's Current Deferred Revenue (Quarter) stood at $3.6 billion in 2021, then rose by 13.27% to $4.1 billion in 2022, then increased by 10.5% to $4.5 billion in 2023, then grew by 2.16% to $4.6 billion in 2024, then rose by 9.49% to $5.1 billion in 2025.
  • Its Current Deferred Revenue stands at $5.1 billion for Q3 2025, versus $4.9 billion for Q2 2025 and $4.7 billion for Q1 2025.